ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q2Scopus Q1SCImago #3,550Top JournalGold OA

Orphanet Journal of Rare Diseases

Acronym:ojrd
•
Abbreviation (ISO):ORPHANET J RARE DIS
•
Identifier (ISSN):1750-1172(Print)
•
Publisher:BioMed Central
Clarivate IF (2026)
3.6↑ +0.1
Journal Impact Factor
IF Trend↓
WoS Quartile
Q2
WoS SCIETop Tier
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Orphanet Journal of Rare Diseases

WoS Q2
23563.6120183.6920193.5220204.1220214.320223.720233.420243.520253.62026
Annual Impact Factor Metric
Current (2026):3.6
Scopus SJR & RankScopus Q1
1.218
#3,550

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
150

150 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate5.9%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessGold OA
474articles/year
100% Gold OA•83.22% Original Research

Aims & Scope

Orphanet Journal of Rare Diseases is an open access, peer-reviewed journal that encompasses all aspects of rare diseases and orphan drugs. The journal publishes high-quality reviews on specific rare diseases. In addition, the journal may consider articles on clinical trial outcome reports, either positive or negative, and articles on public health issues in the field of rare diseases and orphan drugs. The journal does not accept case reports.

Topics Covered (Recognized by AI)
MedicineBiologyInternal MedicinePathologyGeneticsChemistryBiochemistryPsychologyPathology & DiseasesSurgeryPsychiatryEndocrinologyMathematicsSociology

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

GENETICS & HEREDITY

Q2
Rank61/192
IndexSCIE
JCRSCIE2026

MEDICINE, RESEARCH & EXPERIMENTAL

Q2
Rank79/191
IndexSCIE
JCISCIE2026

GENETICS & HEREDITY

Q2
Rank76/192
IndexSCIE
JCISCIE2026

MEDICINE, RESEARCH & EXPERIMENTAL

Q2
Rank69/191
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF3.6
Articles / Year432
Total Citations118
2025
IF3.5
Articles / Year663
Total Citations1,808
2024
IF3.4
Articles / Year496
Total Citations3,351
2023
IF3.7
Articles / Year395
Total Citations5,147
2022
IF4.303
Articles / Year453
Total Citations8,721

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #3,550Scopus Q1SCImago Profile
Scopus Coverage:2006-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q1
1.218

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
3.51

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,432 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations5,216
3-Year Documents1,304
Citable Documents1,255

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)1

Citations in government and international policy documents

Female Author Rate55.1%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Medicine (miscellaneous)Q1
Pharmacology (medical)Q1
Genetics (clinical)Q2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 5.9%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
2区 (Zone 2)Medicine
Minor Category (Specific Field):
2区GENETICS & HEREDITY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Orphanet Journal of Rare Diseases (acronym: ojrd, abbr: ORPHANET J RARE DIS, ISSN: 1750-1172) is a peer-reviewed international scholarly journal in the field of Medicine, published by BioMed Central in England since 2006. The periodical holds a Journal Impact Factor (JIF) of 3.60, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 1.218 (Q1), an H-index of 150.

The journal enforces rigorous peer evaluation with a publication frequency of Irregular, an annual output of approximately 474 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $3,432 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Gold OA
Publisher
BioMed Central
Publication Language
English
Frequency
Irregular
Founding Year
2006
Indexing & Databases
SCIEScopusDOAJPubMed
Editorial Address
BIOMED CENTRAL LTD, 236 GRAYS INN RD, FLOOR 6, LONDON, ENGLAND, WC1X 8HL

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 33797374-32df-4185-96e5-d4b0797396dc
Database Updated: 2026-09-28